| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticarcinogenic Agents | 44 | 2016 | 75 | 6.120 |
Why?
|
| Stilbenes | 28 | 2016 | 48 | 4.880 |
Why?
|
| Antineoplastic Agents, Phytogenic | 45 | 2022 | 89 | 4.190 |
Why?
|
| Plant Extracts | 49 | 2025 | 170 | 4.070 |
Why?
|
| Vitis | 6 | 2025 | 11 | 3.510 |
Why?
|
| Plants, Medicinal | 41 | 2019 | 59 | 3.220 |
Why?
|
| NF-kappa B | 40 | 2025 | 467 | 2.910 |
Why?
|
| Antineoplastic Agents | 31 | 2018 | 649 | 2.550 |
Why?
|
| Neoplasms | 24 | 2016 | 1325 | 2.520 |
Why?
|
| Phytotherapy | 17 | 2016 | 53 | 2.260 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 34 | 2018 | 43 | 2.040 |
Why?
|
| Molecular Structure | 79 | 2020 | 377 | 1.820 |
Why?
|
| Nitric Oxide Synthase Type II | 10 | 2023 | 70 | 1.800 |
Why?
|
| Physalis | 7 | 2025 | 7 | 1.760 |
Why?
|
| Withanolides | 6 | 2025 | 6 | 1.730 |
Why?
|
| Flavonoids | 18 | 2018 | 74 | 1.680 |
Why?
|
| Biological Products | 9 | 2020 | 94 | 1.640 |
Why?
|
| Antioxidants | 14 | 2018 | 247 | 1.500 |
Why?
|
| Chemoprevention | 14 | 2018 | 39 | 1.420 |
Why?
|
| Animals | 109 | 2025 | 20218 | 1.400 |
Why?
|
| Cyclooxygenase 2 | 16 | 2019 | 75 | 1.380 |
Why?
|
| Inhibitory Concentration 50 | 42 | 2018 | 89 | 1.260 |
Why?
|
| Aromatase Inhibitors | 14 | 2018 | 24 | 1.120 |
Why?
|
| Licensure, Pharmacy | 2 | 2024 | 4 | 1.120 |
Why?
|
| Pharmacists | 3 | 2024 | 123 | 1.100 |
Why?
|
| Apoptosis | 14 | 2016 | 1047 | 1.080 |
Why?
|
| Mice | 75 | 2025 | 10603 | 1.070 |
Why?
|
| Students, Pharmacy | 2 | 2024 | 13 | 1.060 |
Why?
|
| Lactones | 10 | 2019 | 24 | 1.050 |
Why?
|
| Humans | 147 | 2025 | 61728 | 1.040 |
Why?
|
| Cyclooxygenase Inhibitors | 16 | 2011 | 43 | 1.020 |
Why?
|
| Triterpenes | 15 | 2016 | 21 | 1.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 18 | 2025 | 592 | 1.010 |
Why?
|
| Educational Measurement | 2 | 2024 | 215 | 0.980 |
Why?
|
| Magnoliopsida | 4 | 2021 | 8 | 0.970 |
Why?
|
| Pharmacy | 2 | 2023 | 19 | 0.950 |
Why?
|
| Anti-Inflammatory Agents | 10 | 2025 | 169 | 0.930 |
Why?
|
| Isoquinolines | 4 | 2013 | 33 | 0.930 |
Why?
|
| Drug Screening Assays, Antitumor | 41 | 2015 | 81 | 0.920 |
Why?
|
| Structure-Activity Relationship | 30 | 2018 | 368 | 0.910 |
Why?
|
| Education, Pharmacy | 2 | 2024 | 18 | 0.910 |
Why?
|
| Tumor Cells, Cultured | 38 | 2014 | 451 | 0.880 |
Why?
|
| Accreditation | 1 | 2024 | 73 | 0.870 |
Why?
|
| Fruit | 10 | 2025 | 107 | 0.850 |
Why?
|
| Indenes | 3 | 2012 | 15 | 0.840 |
Why?
|
| Aromatase | 10 | 2018 | 14 | 0.840 |
Why?
|
| Lipopolysaccharides | 11 | 2023 | 637 | 0.840 |
Why?
|
| Kidney | 3 | 2024 | 441 | 0.830 |
Why?
|
| Phenazines | 3 | 2012 | 10 | 0.830 |
Why?
|
| Aquatic Organisms | 3 | 2013 | 8 | 0.820 |
Why?
|
| Quassins | 4 | 2016 | 4 | 0.800 |
Why?
|
| Cell Line, Tumor | 36 | 2022 | 1417 | 0.770 |
Why?
|
| Vitaceae | 1 | 2021 | 1 | 0.760 |
Why?
|
| Nitric Oxide | 16 | 2025 | 143 | 0.760 |
Why?
|
| Parasites | 1 | 2021 | 12 | 0.760 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2019 | 197 | 0.740 |
Why?
|
| Universities | 3 | 2023 | 153 | 0.730 |
Why?
|
| Sesquiterpenes | 10 | 2020 | 14 | 0.730 |
Why?
|
| Microbiota | 1 | 2023 | 122 | 0.730 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 205 | 0.720 |
Why?
|
| Drug Discovery | 5 | 2012 | 92 | 0.720 |
Why?
|
| Carbolines | 3 | 2018 | 9 | 0.680 |
Why?
|
| Macrophages | 11 | 2025 | 1028 | 0.670 |
Why?
|
| Quinone Reductases | 9 | 2015 | 11 | 0.660 |
Why?
|
| Dietary Supplements | 3 | 2024 | 229 | 0.660 |
Why?
|
| Retinoid X Receptors | 5 | 2012 | 15 | 0.650 |
Why?
|
| Thiazoles | 4 | 2013 | 47 | 0.640 |
Why?
|
| Anti-HIV Agents | 8 | 2016 | 154 | 0.630 |
Why?
|
| STAT1 Transcription Factor | 1 | 2019 | 35 | 0.620 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2013 | 149 | 0.620 |
Why?
|
| Biological Factors | 2 | 2013 | 21 | 0.610 |
Why?
|
| Streptomyces | 4 | 2014 | 19 | 0.600 |
Why?
|
| Chalcones | 6 | 2010 | 6 | 0.580 |
Why?
|
| Alkaloids | 4 | 2023 | 12 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3335 | 0.570 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2025 | 822 | 0.560 |
Why?
|
| Cell Line | 18 | 2016 | 2018 | 0.550 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 30 | 2014 | 112 | 0.540 |
Why?
|
| KB Cells | 13 | 2005 | 15 | 0.530 |
Why?
|
| Phytochemicals | 2 | 2016 | 22 | 0.530 |
Why?
|
| Endophytes | 1 | 2016 | 1 | 0.520 |
Why?
|
| Taxus | 1 | 2016 | 9 | 0.520 |
Why?
|
| Diterpenes | 8 | 2014 | 21 | 0.510 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 137 | 0.510 |
Why?
|
| Pharmacology | 2 | 2016 | 5 | 0.510 |
Why?
|
| Histone Code | 1 | 2016 | 27 | 0.510 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 46 | 0.500 |
Why?
|
| Bacteria | 4 | 2012 | 300 | 0.500 |
Why?
|
| Tropanes | 4 | 2003 | 6 | 0.500 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2016 | 51 | 0.500 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2010 | 62 | 0.490 |
Why?
|
| DNA Damage | 2 | 2016 | 284 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 773 | 0.480 |
Why?
|
| Dog Diseases | 1 | 2016 | 60 | 0.480 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 64 | 0.480 |
Why?
|
| Education, Graduate | 1 | 2015 | 16 | 0.470 |
Why?
|
| Isothiocyanates | 4 | 2011 | 14 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2008 | 203 | 0.460 |
Why?
|
| Euphorbiaceae | 3 | 2010 | 3 | 0.460 |
Why?
|
| Glycosides | 6 | 2011 | 10 | 0.460 |
Why?
|
| Moringa oleifera | 2 | 2011 | 2 | 0.460 |
Why?
|
| Enzyme Induction | 19 | 2012 | 45 | 0.460 |
Why?
|
| HL-60 Cells | 7 | 2012 | 25 | 0.460 |
Why?
|
| Plant Preparations | 2 | 2016 | 15 | 0.450 |
Why?
|
| Cosmetics | 1 | 2013 | 16 | 0.430 |
Why?
|
| Flavones | 4 | 2008 | 52 | 0.430 |
Why?
|
| Isoenzymes | 11 | 2004 | 139 | 0.430 |
Why?
|
| Drug Resistance, Multiple | 4 | 2003 | 33 | 0.410 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 170 | 0.410 |
Why?
|
| Cell Survival | 11 | 2018 | 566 | 0.410 |
Why?
|
| Furans | 5 | 2006 | 33 | 0.410 |
Why?
|
| Pharmacognosy | 2 | 2011 | 2 | 0.400 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 428 | 0.400 |
Why?
|
| Phosphorylation | 7 | 2019 | 924 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2010 | 497 | 0.390 |
Why?
|
| Diet | 3 | 2024 | 511 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2012 | 246 | 0.390 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 408 | 0.380 |
Why?
|
| Fragaria | 1 | 2012 | 5 | 0.380 |
Why?
|
| Colonic Neoplasms | 6 | 2007 | 217 | 0.380 |
Why?
|
| Rhamnose | 1 | 2011 | 2 | 0.370 |
Why?
|
| Plant Leaves | 18 | 2015 | 38 | 0.370 |
Why?
|
| Capsaicin | 1 | 2011 | 17 | 0.370 |
Why?
|
| Health Promotion | 3 | 2015 | 490 | 0.360 |
Why?
|
| Plant Stems | 14 | 2014 | 17 | 0.360 |
Why?
|
| Phenols | 6 | 2017 | 77 | 0.360 |
Why?
|
| Caco-2 Cells | 4 | 2016 | 68 | 0.360 |
Why?
|
| Magnetic Resonance Spectroscopy | 18 | 2017 | 289 | 0.360 |
Why?
|
| Gallic Acid | 1 | 2010 | 3 | 0.360 |
Why?
|
| Fluorenes | 1 | 2010 | 14 | 0.350 |
Why?
|
| Lignans | 7 | 2016 | 15 | 0.350 |
Why?
|
| Solanaceae | 4 | 2003 | 4 | 0.350 |
Why?
|
| Stereoisomerism | 23 | 2009 | 68 | 0.350 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 82 | 0.350 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 186 | 0.340 |
Why?
|
| Rats | 9 | 2012 | 1927 | 0.340 |
Why?
|
| Antimalarials | 6 | 2006 | 84 | 0.330 |
Why?
|
| I-kappa B Proteins | 2 | 2013 | 39 | 0.330 |
Why?
|
| Enzyme Inhibitors | 8 | 2011 | 354 | 0.330 |
Why?
|
| Curcumin | 2 | 2016 | 78 | 0.330 |
Why?
|
| Indoles | 4 | 2018 | 108 | 0.330 |
Why?
|
| Chalcone | 3 | 2006 | 3 | 0.320 |
Why?
|
| Depsipeptides | 1 | 2009 | 5 | 0.320 |
Why?
|
| Actinobacteria | 1 | 2009 | 8 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 222 | 0.320 |
Why?
|
| Organoselenium Compounds | 2 | 2015 | 4 | 0.310 |
Why?
|
| Hawaii | 4 | 2020 | 22 | 0.310 |
Why?
|
| Molecular Conformation | 17 | 2017 | 131 | 0.310 |
Why?
|
| Cell Nucleus | 3 | 2016 | 614 | 0.310 |
Why?
|
| Saponins | 3 | 2004 | 28 | 0.310 |
Why?
|
| Female | 26 | 2024 | 31963 | 0.300 |
Why?
|
| Porifera | 4 | 2014 | 7 | 0.300 |
Why?
|
| Crystallography, X-Ray | 18 | 2015 | 424 | 0.300 |
Why?
|
| Anthracenes | 2 | 2005 | 15 | 0.290 |
Why?
|
| Mass Spectrometry | 10 | 2010 | 302 | 0.290 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 12 | 2010 | 36 | 0.280 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 1585 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 10 | 2013 | 171 | 0.280 |
Why?
|
| RAW 264.7 Cells | 4 | 2025 | 54 | 0.280 |
Why?
|
| Nitric Oxide Synthase | 4 | 2012 | 39 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2013 | 214 | 0.280 |
Why?
|
| Brucea | 2 | 2004 | 2 | 0.270 |
Why?
|
| Cyclooxygenase 1 | 12 | 2010 | 18 | 0.270 |
Why?
|
| Drug Design | 4 | 2013 | 134 | 0.270 |
Why?
|
| Cell Proliferation | 8 | 2016 | 962 | 0.270 |
Why?
|
| Vinblastine | 3 | 2003 | 18 | 0.260 |
Why?
|
| Malvaceae | 2 | 2023 | 2 | 0.260 |
Why?
|
| Thiocyanates | 2 | 2005 | 7 | 0.260 |
Why?
|
| Models, Molecular | 12 | 2016 | 1133 | 0.250 |
Why?
|
| Chromatography, Liquid | 8 | 2010 | 129 | 0.250 |
Why?
|
| Microsomes, Liver | 5 | 2013 | 21 | 0.250 |
Why?
|
| Lauraceae | 2 | 2004 | 2 | 0.250 |
Why?
|
| Erythroxylaceae | 2 | 2002 | 2 | 0.250 |
Why?
|
| Steroids | 2 | 2003 | 52 | 0.240 |
Why?
|
| Diet, Mediterranean | 1 | 2025 | 17 | 0.240 |
Why?
|
| Multiple Myeloma | 2 | 2016 | 344 | 0.240 |
Why?
|
| Litsea | 3 | 2016 | 3 | 0.240 |
Why?
|
| Simaroubaceae | 1 | 2005 | 1 | 0.240 |
Why?
|
| Monosaccharides | 1 | 2005 | 8 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 9 | 2010 | 880 | 0.230 |
Why?
|
| Flowers | 3 | 2021 | 4 | 0.230 |
Why?
|
| Colon | 4 | 2010 | 136 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 449 | 0.230 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 3 | 2015 | 23 | 0.230 |
Why?
|
| Drug Resistance | 1 | 2005 | 112 | 0.230 |
Why?
|
| Schools, Pharmacy | 1 | 2024 | 7 | 0.230 |
Why?
|
| Pentacyclic Triterpenes | 5 | 2015 | 6 | 0.220 |
Why?
|
| Pyrones | 2 | 2017 | 7 | 0.220 |
Why?
|
| Rotenone | 4 | 2005 | 10 | 0.220 |
Why?
|
| North America | 1 | 2024 | 110 | 0.220 |
Why?
|
| Marine Biology | 5 | 2010 | 5 | 0.220 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 10 | 2004 | 29 | 0.220 |
Why?
|
| History, 21st Century | 2 | 2015 | 168 | 0.220 |
Why?
|
| MCF-7 Cells | 4 | 2016 | 69 | 0.220 |
Why?
|
| Quercetin | 2 | 2016 | 27 | 0.220 |
Why?
|
| Cell Differentiation | 5 | 2007 | 1327 | 0.220 |
Why?
|
| Malaria, Falciparum | 1 | 2005 | 142 | 0.210 |
Why?
|
| Prostatic Neoplasms | 4 | 2003 | 385 | 0.210 |
Why?
|
| Benzofurans | 3 | 2017 | 11 | 0.210 |
Why?
|
| Plasma | 1 | 2023 | 36 | 0.210 |
Why?
|
| HCT116 Cells | 2 | 2016 | 50 | 0.210 |
Why?
|
| Withania | 2 | 2013 | 3 | 0.210 |
Why?
|
| Public Health | 2 | 2015 | 184 | 0.210 |
Why?
|
| Astragalus Plant | 1 | 2002 | 1 | 0.200 |
Why?
|
| Quinolines | 1 | 2023 | 41 | 0.200 |
Why?
|
| Metabolomics | 1 | 2023 | 54 | 0.200 |
Why?
|
| Fenretinide | 1 | 2002 | 3 | 0.200 |
Why?
|
| Glutathione Transferase | 3 | 2015 | 36 | 0.200 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2002 | 4 | 0.200 |
Why?
|
| Lavandula | 1 | 2002 | 1 | 0.200 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2008 | 66 | 0.200 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 5 | 2007 | 7 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2013 | 603 | 0.200 |
Why?
|
| Oxidative Stress | 2 | 2016 | 289 | 0.200 |
Why?
|
| Melanoma | 2 | 2003 | 327 | 0.200 |
Why?
|
| Diosgenin | 1 | 2002 | 1 | 0.200 |
Why?
|
| Brassicaceae | 1 | 2002 | 1 | 0.200 |
Why?
|
| Tretinoin | 1 | 2002 | 51 | 0.200 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 98 | 0.200 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 77 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2010 | 229 | 0.200 |
Why?
|
| Oils, Volatile | 1 | 2002 | 22 | 0.190 |
Why?
|
| Male | 11 | 2024 | 28958 | 0.190 |
Why?
|
| Signal Transduction | 6 | 2019 | 2977 | 0.190 |
Why?
|
| History, 20th Century | 2 | 2015 | 228 | 0.190 |
Why?
|
| Research | 2 | 2015 | 190 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 594 | 0.190 |
Why?
|
| Lymphocytes | 1 | 2002 | 194 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2022 | 52 | 0.190 |
Why?
|
| Drug Synergism | 3 | 2009 | 134 | 0.190 |
Why?
|
| Glutathione | 3 | 2010 | 54 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 226 | 0.180 |
Why?
|
| Caspases | 3 | 2011 | 171 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 222 | 0.180 |
Why?
|
| Reproduction | 1 | 2021 | 92 | 0.180 |
Why?
|
| Ellagic Acid | 2 | 2016 | 2 | 0.180 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 171 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 192 | 0.180 |
Why?
|
| Ornithine Decarboxylase | 5 | 2010 | 10 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 129 | 0.180 |
Why?
|
| Plant Components, Aerial | 3 | 2025 | 6 | 0.180 |
Why?
|
| Quinolones | 2 | 2012 | 27 | 0.180 |
Why?
|
| Polypodiaceae | 2 | 2011 | 2 | 0.170 |
Why?
|
| Plant Bark | 10 | 2006 | 12 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 754 | 0.170 |
Why?
|
| Fusidic Acid | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cell Division | 5 | 2007 | 446 | 0.170 |
Why?
|
| Cyclohexanes | 1 | 2020 | 4 | 0.170 |
Why?
|
| Carcinogens | 4 | 2008 | 37 | 0.170 |
Why?
|
| Naphthoquinones | 3 | 2005 | 5 | 0.170 |
Why?
|
| Aspergillus | 1 | 2020 | 11 | 0.170 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 28 | 0.170 |
Why?
|
| HT29 Cells | 3 | 2016 | 27 | 0.170 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2013 | 27 | 0.170 |
Why?
|
| Sulfuric Acid Esters | 2 | 2010 | 6 | 0.170 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 4 | 2008 | 8 | 0.160 |
Why?
|
| Membrane Potentials | 3 | 2005 | 141 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2020 | 199 | 0.160 |
Why?
|
| Lamiaceae | 2 | 2014 | 3 | 0.160 |
Why?
|
| Breast Neoplasms | 5 | 2015 | 1169 | 0.160 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 199 | 0.160 |
Why?
|
| Antitubercular Agents | 2 | 2012 | 81 | 0.150 |
Why?
|
| Polymers | 1 | 2002 | 320 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 6 | 2010 | 34 | 0.150 |
Why?
|
| Euphorbia | 2 | 2012 | 3 | 0.150 |
Why?
|
| Sirtuin 1 | 2 | 2016 | 27 | 0.150 |
Why?
|
| Casimiroa | 2 | 2009 | 2 | 0.150 |
Why?
|
| Cell Cycle | 4 | 2011 | 382 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2010 | 94 | 0.150 |
Why?
|
| Citrus | 1 | 2018 | 41 | 0.150 |
Why?
|
| Liver | 4 | 2022 | 826 | 0.140 |
Why?
|
| Heliotropium | 1 | 2017 | 1 | 0.140 |
Why?
|
| Safrole | 1 | 2017 | 1 | 0.140 |
Why?
|
| Lactams | 1 | 2017 | 18 | 0.140 |
Why?
|
| Ascomycota | 1 | 2017 | 12 | 0.140 |
Why?
|
| Sulfides | 1 | 2017 | 22 | 0.140 |
Why?
|
| Dinoprostone | 2 | 2009 | 41 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 449 | 0.140 |
Why?
|
| Amides | 1 | 2017 | 55 | 0.140 |
Why?
|
| Enzyme Activation | 4 | 2011 | 377 | 0.140 |
Why?
|
| Disease Models, Animal | 7 | 2007 | 2116 | 0.140 |
Why?
|
| Peptides | 2 | 2015 | 568 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 295 | 0.130 |
Why?
|
| Gardenia | 1 | 2016 | 3 | 0.130 |
Why?
|
| Plasmodium falciparum | 5 | 2006 | 167 | 0.130 |
Why?
|
| HEK293 Cells | 5 | 2020 | 604 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2019 | 258 | 0.130 |
Why?
|
| Disaccharidases | 1 | 2016 | 1 | 0.130 |
Why?
|
| Morinda | 1 | 2016 | 1 | 0.130 |
Why?
|
| Genistein | 1 | 2016 | 9 | 0.130 |
Why?
|
| Food, Formulated | 1 | 2016 | 10 | 0.130 |
Why?
|
| Rhizophoraceae | 2 | 2006 | 2 | 0.130 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 77 | 0.130 |
Why?
|
| Hedera | 1 | 2015 | 1 | 0.130 |
Why?
|
| Seeds | 4 | 2004 | 31 | 0.130 |
Why?
|
| Indonesia | 9 | 2009 | 19 | 0.130 |
Why?
|
| Cytarabine | 1 | 2015 | 35 | 0.130 |
Why?
|
| Chaetomium | 1 | 2015 | 1 | 0.120 |
Why?
|
| Fermentation | 2 | 2016 | 46 | 0.120 |
Why?
|
| Benzopyrans | 1 | 2015 | 6 | 0.120 |
Why?
|
| Flow Cytometry | 4 | 2007 | 664 | 0.120 |
Why?
|
| Lung Neoplasms | 5 | 2005 | 636 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 41 | 0.120 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 47 | 0.120 |
Why?
|
| Health | 1 | 2015 | 31 | 0.120 |
Why?
|
| Ferrous Compounds | 1 | 2015 | 12 | 0.120 |
Why?
|
| Ergosterol | 2 | 2006 | 3 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 457 | 0.120 |
Why?
|
| Acetates | 1 | 2015 | 32 | 0.120 |
Why?
|
| Urea | 1 | 2015 | 36 | 0.120 |
Why?
|
| History, Medieval | 1 | 2015 | 2 | 0.120 |
Why?
|
| History, Ancient | 1 | 2015 | 11 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 69 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2015 | 44 | 0.120 |
Why?
|
| Rubiaceae | 2 | 2005 | 3 | 0.120 |
Why?
|
| Dogs | 1 | 2016 | 324 | 0.120 |
Why?
|
| Melastomataceae | 2 | 2006 | 2 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 47 | 0.110 |
Why?
|
| Bronchial Neoplasms | 2 | 2005 | 6 | 0.110 |
Why?
|
| Esters | 3 | 2003 | 18 | 0.110 |
Why?
|
| Isoflavones | 3 | 2003 | 16 | 0.110 |
Why?
|
| Cells, Cultured | 5 | 2013 | 2135 | 0.110 |
Why?
|
| Small Molecule Libraries | 2 | 2012 | 57 | 0.110 |
Why?
|
| Aglaia | 2 | 2004 | 2 | 0.110 |
Why?
|
| Asparagus Plant | 2 | 2004 | 2 | 0.110 |
Why?
|
| Respiratory Mucosa | 2 | 2005 | 53 | 0.110 |
Why?
|
| Purine Nucleosides | 1 | 2014 | 1 | 0.110 |
Why?
|
| Molecular Docking Simulation | 4 | 2017 | 78 | 0.110 |
Why?
|
| Kaempferols | 2 | 2011 | 3 | 0.110 |
Why?
|
| Intracellular Membranes | 2 | 2005 | 50 | 0.110 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2005 | 6 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 42 | 0.110 |
Why?
|
| Mammary Glands, Animal | 3 | 2003 | 77 | 0.110 |
Why?
|
| Pyrrolidines | 1 | 2013 | 11 | 0.110 |
Why?
|
| Plant Roots | 5 | 2010 | 62 | 0.110 |
Why?
|
| Patents as Topic | 1 | 2013 | 7 | 0.110 |
Why?
|
| Azepines | 1 | 2013 | 20 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2004 | 77 | 0.110 |
Why?
|
| Receptors, Serotonin | 2 | 2003 | 16 | 0.110 |
Why?
|
| Glucuronosyltransferase | 2 | 2015 | 11 | 0.110 |
Why?
|
| Coumarins | 3 | 2018 | 6 | 0.110 |
Why?
|
| Cimicifuga | 2 | 2003 | 2 | 0.110 |
Why?
|
| Micromonospora | 1 | 2013 | 1 | 0.110 |
Why?
|
| COS Cells | 1 | 2013 | 173 | 0.100 |
Why?
|
| Imidazoles | 1 | 2013 | 80 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2004 | 105 | 0.100 |
Why?
|
| Ethnobotany | 1 | 2012 | 1 | 0.100 |
Why?
|
| Macrolides | 1 | 2013 | 35 | 0.100 |
Why?
|
| Young Adult | 1 | 2023 | 4541 | 0.100 |
Why?
|
| Pakistan | 1 | 2012 | 15 | 0.100 |
Why?
|
| Intestinal Absorption | 2 | 2010 | 30 | 0.100 |
Why?
|
| Fabaceae | 2 | 2003 | 9 | 0.100 |
Why?
|
| Luciferases | 2 | 2010 | 109 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 4 | 2011 | 93 | 0.100 |
Why?
|
| Histones | 1 | 2016 | 470 | 0.100 |
Why?
|
| Vernonia | 1 | 2012 | 1 | 0.100 |
Why?
|
| Ficus | 2 | 2002 | 3 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 2012 | 21 | 0.100 |
Why?
|
| Phytosterols | 2 | 2002 | 8 | 0.100 |
Why?
|
| Proteasome Inhibitors | 1 | 2012 | 30 | 0.100 |
Why?
|
| Chloroform | 2 | 2022 | 6 | 0.100 |
Why?
|
| Terpenes | 2 | 2002 | 27 | 0.100 |
Why?
|
| Anti-Infective Agents | 3 | 2017 | 148 | 0.100 |
Why?
|
| Catalytic Domain | 4 | 2017 | 197 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2011 | 371 | 0.100 |
Why?
|
| Peroxides | 2 | 2010 | 11 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2012 | 119 | 0.100 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2012 | 20 | 0.100 |
Why?
|
| United States | 2 | 2024 | 7625 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 35 | 0.090 |
Why?
|
| G2 Phase | 1 | 2011 | 24 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2010 | 145 | 0.090 |
Why?
|
| G1 Phase | 1 | 2012 | 55 | 0.090 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 30 | 0.090 |
Why?
|
| Immunoblotting | 4 | 2005 | 201 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 452 | 0.090 |
Why?
|
| Thiadiazoles | 1 | 2011 | 5 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2003 | 223 | 0.090 |
Why?
|
| HIV-1 | 3 | 2016 | 708 | 0.090 |
Why?
|
| Time Factors | 5 | 2007 | 3706 | 0.090 |
Why?
|
| Biological Availability | 1 | 2012 | 199 | 0.090 |
Why?
|
| Capsicum | 1 | 2011 | 2 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 80 | 0.090 |
Why?
|
| Isodon | 1 | 2011 | 1 | 0.090 |
Why?
|
| Caffeic Acids | 1 | 2011 | 2 | 0.090 |
Why?
|
| Transfection | 2 | 2011 | 681 | 0.090 |
Why?
|
| Cassia | 1 | 2011 | 1 | 0.090 |
Why?
|
| Humulus | 1 | 2010 | 1 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 71 | 0.090 |
Why?
|
| Mitochondria | 2 | 2005 | 357 | 0.090 |
Why?
|
| Organ Culture Techniques | 7 | 2003 | 66 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2012 | 146 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2010 | 65 | 0.090 |
Why?
|
| Peru | 5 | 2016 | 12 | 0.090 |
Why?
|
| Actinomycetales | 1 | 2010 | 3 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2010 | 76 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 185 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 857 | 0.090 |
Why?
|
| Glycyrrhiza | 1 | 2010 | 3 | 0.080 |
Why?
|
| Functional Food | 1 | 2010 | 37 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1123 | 0.080 |
Why?
|
| Membrane Proteins | 6 | 2004 | 876 | 0.080 |
Why?
|
| Gene Expression | 2 | 2011 | 829 | 0.080 |
Why?
|
| Hyptis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Apocynaceae | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cyclitols | 1 | 2009 | 1 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 591 | 0.080 |
Why?
|
| Binding Sites | 4 | 2017 | 891 | 0.080 |
Why?
|
| Sesterterpenes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Benzodioxoles | 1 | 2009 | 13 | 0.080 |
Why?
|
| Leukemia P388 | 3 | 2004 | 3 | 0.080 |
Why?
|
| 4-Butyrolactone | 2 | 2006 | 3 | 0.080 |
Why?
|
| Plant Shoots | 3 | 2003 | 7 | 0.080 |
Why?
|
| Sulfoxides | 2 | 2005 | 16 | 0.080 |
Why?
|
| Aldehyde Reductase | 1 | 2008 | 4 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 2008 | 9 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 536 | 0.080 |
Why?
|
| Isocoumarins | 1 | 2008 | 1 | 0.070 |
Why?
|
| Protein Binding | 2 | 2010 | 1581 | 0.070 |
Why?
|
| Verapamil | 2 | 2005 | 9 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2015 | 527 | 0.070 |
Why?
|
| Chloroquine | 2 | 2005 | 54 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2012 | 403 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 27 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 65 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 636 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 321 | 0.070 |
Why?
|
| Manilkara | 1 | 2007 | 1 | 0.070 |
Why?
|
| Actinomyces | 1 | 2007 | 2 | 0.070 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2007 | 21 | 0.070 |
Why?
|
| Vitamin K 3 | 2 | 2005 | 2 | 0.070 |
Why?
|
| Rhodophyta | 1 | 2006 | 2 | 0.070 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2006 | 3 | 0.070 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2006 | 7 | 0.070 |
Why?
|
| Vietnam | 4 | 2014 | 172 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 184 | 0.070 |
Why?
|
| Connaraceae | 1 | 2006 | 1 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2006 | 316 | 0.070 |
Why?
|
| Precancerous Conditions | 2 | 2007 | 70 | 0.070 |
Why?
|
| Guaiacol | 1 | 2006 | 2 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2005 | 41 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2005 | 336 | 0.070 |
Why?
|
| Ericaceae | 1 | 2006 | 1 | 0.060 |
Why?
|
| Malpighiaceae | 1 | 2006 | 1 | 0.060 |
Why?
|
| Thiosulfonic Acids | 1 | 2006 | 1 | 0.060 |
Why?
|
| Glycolipids | 1 | 2006 | 42 | 0.060 |
Why?
|
| Annonaceae | 1 | 2006 | 2 | 0.060 |
Why?
|
| Sambucus | 1 | 2006 | 1 | 0.060 |
Why?
|
| Adult | 1 | 2023 | 16370 | 0.060 |
Why?
|
| Spiro Compounds | 1 | 2006 | 10 | 0.060 |
Why?
|
| Spodoptera | 1 | 2006 | 28 | 0.060 |
Why?
|
| Fatty Acids | 2 | 2018 | 197 | 0.060 |
Why?
|
| Middle Aged | 1 | 2023 | 17090 | 0.060 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 44 | 0.060 |
Why?
|
| Biodiversity | 1 | 2006 | 37 | 0.060 |
Why?
|
| Avicennia | 1 | 2005 | 1 | 0.060 |
Why?
|
| Drug Industry | 1 | 2006 | 39 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 170 | 0.060 |
Why?
|
| Geography | 1 | 2005 | 35 | 0.060 |
Why?
|
| Scrophulariaceae | 1 | 2005 | 1 | 0.060 |
Why?
|
| Brassica | 1 | 2005 | 7 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1582 | 0.060 |
Why?
|
| Sheep | 1 | 2006 | 175 | 0.060 |
Why?
|
| Benzylisoquinolines | 1 | 2005 | 1 | 0.060 |
Why?
|
| Quinine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2005 | 52 | 0.060 |
Why?
|
| Myrtaceae | 1 | 2005 | 1 | 0.060 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2005 | 9 | 0.060 |
Why?
|
| Drug Antagonism | 1 | 2005 | 9 | 0.060 |
Why?
|
| Spectrophotometry, Ultraviolet | 4 | 2008 | 47 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2005 | 57 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5502 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 879 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 20 | 0.060 |
Why?
|
| Simarouba | 1 | 2005 | 1 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2005 | 20 | 0.060 |
Why?
|
| Plasmodium berghei | 1 | 2005 | 21 | 0.060 |
Why?
|
| Parasitemia | 1 | 2005 | 38 | 0.060 |
Why?
|
| Vagina | 2 | 2003 | 82 | 0.060 |
Why?
|
| Menispermaceae | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ribonucleotide Reductases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2005 | 149 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 106 | 0.060 |
Why?
|
| Brazil | 2 | 2018 | 98 | 0.060 |
Why?
|
| Diospyros | 1 | 2004 | 1 | 0.060 |
Why?
|
| Strychnos | 1 | 2004 | 1 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 321 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 47 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2005 | 103 | 0.060 |
Why?
|
| Estradiol | 2 | 2002 | 251 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 65 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2002 | 135 | 0.060 |
Why?
|
| Spirostans | 1 | 2004 | 1 | 0.060 |
Why?
|
| Rosaceae | 1 | 2004 | 1 | 0.060 |
Why?
|
| Propidium | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sapindaceae | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ethiopia | 1 | 2004 | 5 | 0.060 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2004 | 9 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2005 | 125 | 0.060 |
Why?
|
| Picrates | 3 | 2010 | 5 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2004 | 31 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 155 | 0.060 |
Why?
|
| Laurencia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2003 | 4 | 0.050 |
Why?
|
| Caspase 7 | 1 | 2004 | 18 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1509 | 0.050 |
Why?
|
| Carbocyanines | 1 | 2004 | 29 | 0.050 |
Why?
|
| Biphenyl Compounds | 3 | 2010 | 32 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2004 | 22 | 0.050 |
Why?
|
| Clusiaceae | 1 | 2003 | 1 | 0.050 |
Why?
|
| Tephrosia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Millettia | 1 | 2003 | 2 | 0.050 |
Why?
|
| Chromones | 1 | 2003 | 20 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 164 | 0.050 |
Why?
|
| Plants | 1 | 2004 | 48 | 0.050 |
Why?
|
| Bronchi | 1 | 2004 | 75 | 0.050 |
Why?
|
| Biological Assay | 1 | 2004 | 57 | 0.050 |
Why?
|
| Vitex | 1 | 2003 | 1 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2004 | 64 | 0.050 |
Why?
|
| Breast | 2 | 2002 | 181 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2005 | 305 | 0.050 |
Why?
|
| Scutellaria | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 34 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2004 | 136 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 101 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2004 | 298 | 0.050 |
Why?
|
| Ericales | 1 | 2003 | 1 | 0.050 |
Why?
|
| Artocarpus | 1 | 2003 | 1 | 0.050 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 30 | 0.050 |
Why?
|
| Ulmaceae | 1 | 2003 | 1 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2003 | 3 | 0.050 |
Why?
|
| Trichothecenes | 1 | 2002 | 1 | 0.050 |
Why?
|
| Araceae | 1 | 2002 | 1 | 0.050 |
Why?
|
| Ziziphus | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oleanolic Acid | 1 | 2002 | 1 | 0.050 |
Why?
|
| Zingiberaceae | 1 | 2002 | 1 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2002 | 2 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2002 | 8 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2002 | 16 | 0.050 |
Why?
|
| Egypt | 1 | 2002 | 7 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 57 | 0.050 |
Why?
|
| Musa | 1 | 2002 | 2 | 0.050 |
Why?
|
| Agaricales | 1 | 2003 | 9 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 20 | 0.050 |
Why?
|
| Chemistry Techniques, Synthetic | 2 | 2013 | 11 | 0.050 |
Why?
|
| Medicine, Traditional | 1 | 2002 | 8 | 0.050 |
Why?
|
| Ellipticines | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pyrans | 1 | 2002 | 2 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2004 | 514 | 0.050 |
Why?
|
| Powders | 1 | 2022 | 19 | 0.050 |
Why?
|
| Protein Transport | 1 | 2004 | 405 | 0.050 |
Why?
|
| Cytotoxins | 1 | 2002 | 12 | 0.050 |
Why?
|
| Rhodamine 123 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 1 | 2002 | 11 | 0.050 |
Why?
|
| Candida | 1 | 2002 | 36 | 0.050 |
Why?
|
| Asteraceae | 1 | 2002 | 2 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 22 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 198 | 0.050 |
Why?
|
| Indole Alkaloids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Moraceae | 1 | 2002 | 1 | 0.050 |
Why?
|
| Phenanthrenes | 1 | 2002 | 7 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2002 | 263 | 0.050 |
Why?
|
| Skin | 1 | 2005 | 370 | 0.050 |
Why?
|
| Trifolium | 1 | 2002 | 3 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 10 | 0.050 |
Why?
|
| Vaccinium macrocarpon | 1 | 2002 | 6 | 0.050 |
Why?
|
| 1-Butanol | 1 | 2022 | 4 | 0.050 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2002 | 10 | 0.050 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 10 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 160 | 0.050 |
Why?
|
| Proanthocyanidins | 1 | 2002 | 16 | 0.050 |
Why?
|
| Anthocyanins | 1 | 2002 | 15 | 0.050 |
Why?
|
| Testosterone | 1 | 2002 | 116 | 0.050 |
Why?
|
| Stomach | 1 | 2002 | 83 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2002 | 95 | 0.050 |
Why?
|
| Uterus | 1 | 2002 | 42 | 0.050 |
Why?
|
| Vegetables | 1 | 2002 | 67 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 234 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 279 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 386 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 710 | 0.050 |
Why?
|
| Florida | 3 | 2005 | 44 | 0.040 |
Why?
|
| Triglycerides | 1 | 2002 | 243 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 240 | 0.040 |
Why?
|
| Body Weight | 1 | 2002 | 373 | 0.040 |
Why?
|
| Biomarkers | 1 | 2006 | 1363 | 0.040 |
Why?
|
| Thailand | 3 | 2006 | 95 | 0.040 |
Why?
|
| Methanol | 3 | 2005 | 12 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 743 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 464 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2004 | 697 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2012 | 468 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1173 | 0.040 |
Why?
|
| Ligands | 2 | 2012 | 415 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 174 | 0.040 |
Why?
|
| Guam | 2 | 2009 | 3 | 0.040 |
Why?
|
| Methylation | 3 | 2003 | 125 | 0.040 |
Why?
|
| Risk Factors | 1 | 2008 | 5242 | 0.040 |
Why?
|
| Epidermis | 3 | 2002 | 37 | 0.040 |
Why?
|
| Putrescine | 1 | 2017 | 1 | 0.040 |
Why?
|
| Shellfish Poisoning | 1 | 2017 | 1 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2017 | 35 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 34 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 56 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 320 | 0.030 |
Why?
|
| Fungi | 1 | 2017 | 57 | 0.030 |
Why?
|
| Lung | 1 | 2002 | 931 | 0.030 |
Why?
|
| Iridoids | 1 | 2016 | 3 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 38 | 0.030 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 2 | 2005 | 13 | 0.030 |
Why?
|
| Metallocenes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Laos | 2 | 2006 | 4 | 0.030 |
Why?
|
| Azoxymethane | 2 | 2007 | 16 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2020 | 700 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 90 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 91 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 55 | 0.030 |
Why?
|
| Alkylation | 2 | 2005 | 15 | 0.030 |
Why?
|
| Hydrolysis | 2 | 2006 | 143 | 0.030 |
Why?
|
| Arabinonucleosides | 1 | 2014 | 2 | 0.030 |
Why?
|
| Virus Replication | 1 | 2016 | 316 | 0.030 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 5 | 0.030 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2013 | 7 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2013 | 27 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 2 | 2004 | 17 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 33 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 59 | 0.030 |
Why?
|
| Acetylation | 2 | 2004 | 118 | 0.030 |
Why?
|
| Ovariectomy | 2 | 2003 | 95 | 0.030 |
Why?
|
| Response Elements | 1 | 2012 | 44 | 0.020 |
Why?
|
| Osteosarcoma | 2 | 2003 | 58 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 123 | 0.020 |
Why?
|
| Enzyme Assays | 1 | 2012 | 15 | 0.020 |
Why?
|
| Drug Stability | 1 | 2012 | 140 | 0.020 |
Why?
|
| Propiophenones | 1 | 2010 | 1 | 0.020 |
Why?
|
| K562 Cells | 1 | 2011 | 57 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 20 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 688 | 0.020 |
Why?
|
| Veratrum | 1 | 2010 | 1 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 25 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 832 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 285 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 766 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 15 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2009 | 11 | 0.020 |
Why?
|
| Anthozoa | 1 | 2009 | 4 | 0.020 |
Why?
|
| Seawater | 1 | 2009 | 11 | 0.020 |
Why?
|
| Yeasts | 1 | 2010 | 51 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 476 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2009 | 54 | 0.020 |
Why?
|
| Quinic Acid | 1 | 2009 | 1 | 0.020 |
Why?
|
| Rutin | 1 | 2009 | 5 | 0.020 |
Why?
|
| Microsomes | 1 | 2008 | 11 | 0.020 |
Why?
|
| Biotransformation | 1 | 2008 | 23 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2008 | 8 | 0.020 |
Why?
|
| Ultrafiltration | 1 | 2007 | 13 | 0.020 |
Why?
|
| Transcription Factor DP1 | 1 | 2006 | 5 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 1 | 2006 | 15 | 0.020 |
Why?
|
| Mexico | 1 | 2006 | 38 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 37 | 0.020 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2006 | 10 | 0.020 |
Why?
|
| S Phase | 1 | 2007 | 75 | 0.020 |
Why?
|
| Philippines | 1 | 2006 | 6 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2006 | 6 | 0.020 |
Why?
|
| Plant Structures | 1 | 2006 | 2 | 0.020 |
Why?
|
| Benzo(a)pyrene | 1 | 2005 | 3 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2006 | 103 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2005 | 9 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2006 | 152 | 0.020 |
Why?
|
| International Cooperation | 1 | 2006 | 85 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 125 | 0.020 |
Why?
|
| Deuterium | 1 | 2005 | 24 | 0.020 |
Why?
|
| Iodoacetamide | 1 | 2005 | 3 | 0.020 |
Why?
|
| Prostaglandin D2 | 1 | 2005 | 4 | 0.020 |
Why?
|
| Dinitrobenzenes | 1 | 2005 | 6 | 0.020 |
Why?
|
| Europe | 1 | 2006 | 190 | 0.020 |
Why?
|
| Calorimetry | 1 | 2005 | 40 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2005 | 25 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 378 | 0.010 |
Why?
|
| Aspergillus niger | 1 | 2004 | 4 | 0.010 |
Why?
|
| beta-Glucosidase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Hydroxycholesterols | 1 | 2004 | 10 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2004 | 23 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2004 | 47 | 0.010 |
Why?
|
| Alcohols | 1 | 2004 | 13 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 30 | 0.010 |
Why?
|
| Crystallization | 1 | 2004 | 97 | 0.010 |
Why?
|
| Stigmasterol | 1 | 2003 | 1 | 0.010 |
Why?
|
| Turkey | 1 | 2003 | 13 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 39 | 0.010 |
Why?
|
| Candida albicans | 1 | 2004 | 71 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 39 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2004 | 94 | 0.010 |
Why?
|
| Myanmar | 1 | 2003 | 8 | 0.010 |
Why?
|
| Rhizome | 1 | 2003 | 2 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1161 | 0.010 |
Why?
|
| Animal Use Alternatives | 1 | 2003 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 102 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 664 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2003 | 98 | 0.010 |
Why?
|
| Acylation | 1 | 2003 | 15 | 0.010 |
Why?
|
| Secosteroids | 1 | 2003 | 1 | 0.010 |
Why?
|
| Piroxicam | 1 | 2003 | 3 | 0.010 |
Why?
|
| Vermont | 1 | 2003 | 16 | 0.010 |
Why?
|
| Chlorophyll | 1 | 2003 | 5 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 119 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2003 | 20 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2D6 Inhibitors | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2003 | 4 | 0.010 |
Why?
|
| Mississippi | 1 | 2003 | 16 | 0.010 |
Why?
|
| Panama | 1 | 2002 | 2 | 0.010 |
Why?
|
| Protein Prenylation | 1 | 2002 | 7 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 173 | 0.010 |
Why?
|
| Sitosterols | 1 | 2002 | 3 | 0.010 |
Why?
|
| Stearic Acids | 1 | 2002 | 9 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 2002 | 14 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2003 | 25 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 57 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2002 | 13 | 0.010 |
Why?
|
| Insecta | 1 | 2003 | 37 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 128 | 0.010 |
Why?
|
| Linoleic Acid | 1 | 2002 | 19 | 0.010 |
Why?
|
| Oleic Acid | 1 | 2002 | 21 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 143 | 0.010 |
Why?
|
| Cucurbitacins | 1 | 2002 | 1 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 46 | 0.010 |
Why?
|
| Endometrium | 1 | 2002 | 30 | 0.010 |
Why?
|
| Tanzania | 1 | 2002 | 23 | 0.010 |
Why?
|
| Wood | 1 | 2002 | 7 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2002 | 49 | 0.010 |
Why?
|
| Cucumis | 1 | 2002 | 1 | 0.010 |
Why?
|
| Singlet Oxygen | 1 | 2002 | 3 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 198 | 0.010 |
Why?
|
| Benz(a)Anthracenes | 1 | 2002 | 1 | 0.010 |
Why?
|
| Dominican Republic | 1 | 2002 | 25 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 2002 | 35 | 0.010 |
Why?
|
| Hot Flashes | 1 | 2003 | 99 | 0.010 |
Why?
|
| Artifacts | 1 | 2003 | 128 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1254 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 333 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 128 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 145 | 0.010 |
Why?
|
| Catechin | 1 | 2002 | 34 | 0.010 |
Why?
|
| Puerto Rico | 1 | 2002 | 131 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 360 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 169 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 389 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 111 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 212 | 0.010 |
Why?
|
| Menopause | 1 | 2003 | 255 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 859 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 555 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 818 | 0.010 |
Why?
|